Literature DB >> 26441247

Viral hepatitis: A new HCV cell culture model for the next clinical challenges.

Che C Colpitts1, Thomas F Baumert1.   

Abstract

Despite advances in hepatitis C treatment, substantial clinical hurdles remain to achieve universal cure and global control of infection. Saeed et al. identified SEC14L2 as a host factor permitting replication of clinical HCV isolates in cell culture, providing a novel system to model infection of patient-derived viruses.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26441247     DOI： 10.1038/nrgastro.2015.170

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

1.  Curing chronic hepatitis C--the arc of a medical triumph.

Authors:  Raymond T Chung; Thomas F Baumert
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

2.  HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Jawad Ilyas; Zhigang Duan; Hashem B El-Serag
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 3.  Treatment of hepatitis C in difficult-to-treat patients.

Authors:  Peter Ferenci
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

Review 4.  Global control of hepatitis C: where challenge meets opportunity.

Authors:  David L Thomas
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 5.  Is genotype 3 of the hepatitis C virus the new villain?

Authors:  Nicolas Goossens; Francesco Negro
Journal:  Hepatology       Date:  2014-04-14       Impact factor: 17.425

Review 6.  A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.

Authors:  Thomas F Baumert; Catherine Fauvelle; Diana Y Chen; Georg M Lauer
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

Review 7.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

8.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

9.  Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation.

Authors:  Daisuke Yamane; David R McGivern; Eliane Wauthier; MinKyung Yi; Victoria J Madden; Christoph Welsch; Iris Antes; Yahong Wen; Pauline E Chugh; Charles E McGee; Douglas G Widman; Ichiro Misumi; Sibali Bandyopadhyay; Seungtaek Kim; Tetsuro Shimakami; Tsunekazu Oikawa; Jason K Whitmire; Mark T Heise; Dirk P Dittmer; C Cheng Kao; Stuart M Pitson; Alfred H Merrill; Lola M Reid; Stanley M Lemon
Journal:  Nat Med       Date:  2014-07-27       Impact factor: 53.440

10.  SEC14L2 enables pan-genotype HCV replication in cell culture.

Authors:  Mohsan Saeed; Ursula Andreo; Hyo-Young Chung; Christine Espiritu; Andrea D Branch; Jose M Silva; Charles M Rice
Journal:  Nature       Date:  2015-08-12       Impact factor: 49.962
  10 in total
  1 in total

1.  Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.

Authors:  Khanit Sa-Ngiamsuntorn; Suradej Hongeng; Adisak Wongkajornsilp
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.